Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data

Octapharma

Status: Completed

Conditions: Bleeding

Treatments: Drug: Fibryga

Study type: Observational

Funder types: Industry

Identifiers

NCT04106895

FORMA-10

Details and patient eligibility

About

To describe the characteristics of patients treated with Fibryga®, the indications and conditions of use of Fibryga® and, for patients treated " on-demand", the short-term outcomes.

Enrollment: 200 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with fibrinogen deficiency (congenital or acquired)
• Having received an treatment with Fibryga® during the recollection period
• Having been informed of the potential retrospective collection of their data by a Clinical Research Associate mandated by Octapharma® when Fibryga® has been delivered and who did not refuse.

Exclusion criteria

• N/A

Trial design

200 participants in 1 patient group

Fibryga

Treatment:

Drug: Fibryga